Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nakanishi ( (JP:7716) ) has shared an update.
Nakanishi Inc. reported that net sales, EBITDA, operating profit and ordinary profit for the year ended December 31, 2025 exceeded earlier forecasts, supported by steady performance in its Dental, DCI, Surgical and Industrial segments and a weaker yen. However, profit attributable to owners of parent fell short of projections after the company booked a ¥13.8 billion impairment loss on goodwill, following a profitability decline at U.S. subsidiary DCI International caused by U.S. government tariff policies.
The goodwill impairment reflects a downward revision in DCI International’s business plan after profit margins deteriorated and performance lagged initial expectations. While the core businesses are performing solidly, the sizeable non-cash charge underscores the earnings sensitivity of recent overseas acquisitions to policy and market shifts, with implications for Nakanishi’s capital efficiency and future M&A strategy.
The most recent analyst rating on (JP:7716) stock is a Hold with a Yen2222.00 price target. To see the full list of analyst forecasts on Nakanishi stock, see the JP:7716 Stock Forecast page.
More about Nakanishi
Nakanishi Inc. is a Tokyo-listed manufacturer specializing in advanced grinding technology for dental, surgical and industrial applications. Its differentiated product lineup, sold under world-class brands in 145 countries, targets the development of medical care and improved quality of life through innovative, high-precision equipment.
Average Trading Volume: 190,531
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen190.9B
Learn more about 7716 stock on TipRanks’ Stock Analysis page.